Week 3B - Protein Expression
Week 3B - Protein Expression
Week 3B - Protein Expression
Fourth Edition
Chapter 5
Nucleic Acids, Gene Expression, and
Recombinant DNA Technology
• Encounter problems
Production of proteins
• Isopropylthiogalactoside
(IPTG) analog of
allolactose
3. DNA digested with 1
restriction enzyme can be
ligated with cloning
vector cut with same
enzyme in any direction
– 50% in wrong direction in
relation to transcriptional
and translational sequences
– Protein not properly
expressed
– Use directional cloning
– Make use of 2 restriction
enzymes
Production of Eukaryotic proteins in
bacteria
• Production of eukaryotic proteins in bacteria – several
problems
1. Eukaryotic control elements for RNA and protein synthesis
not recognised by bacterial hosts
2. Bacteria cannot carry out gene splicing
3. Bacteria lack enzymes to carry out post-translational
processing
4. Eukaryotic proteins maybe degraded by bacterial
proteases
Problems encountered with expression
of eukaryotic proteins in bacteria
• Eukaryotic control elements for RNA and protein synthesis
not recognised by bacterial hosts
– Insert protein encoding part of eukaryotic gene into vector containing
bacterial control elements
• Bacteria cannot carry out gene splicing
– Clone cDNA derived from mature mRNA
– Many mRNAs – not abundant
– If sequence known: chemically synthesize
– Eukaryotic genes: large, not stably synthesized
Problems encountered with expression
of eukaryotic proteins in bacteria
• Bacteria lack enzymes to carry out post-translational
processing
– Currently no general approach to address this problem
• Development of cloning vectors that can propagate in
eukaryotic hosts such as yeast or cultured cells, overcome
these problems
– Baculovirus-based vectors that replicate in cultured insect cells
– Also mammalian expression
– Shuttle vectors: can propagate in yeast and bacteria
• Eukaryotic proteins maybe degraded by bacterial proteases
– Can express eukaryotic protein fused to bacterial protein
– Fused at N-terminal: protected from degradation
– Remove with specific protease
– Can aid in purification process
Application of recombinant
DNA technology
• The ability to produce proteins in large quantities –
enormous impact in medical, agricultural & industrial fields
– Human insulin: diabetes
– Human growth hormone: treat children of abnormal short stature
– Hepatitis B vaccine
– Blood clotting factors: hemophilia
Site-directed mutagenesis
Biotek Instruments
• Presence monitored through UV or blue light
• Can be fused to another protein – monitor expression
• GFP variants – different excitation and emission
wavelengths
• Allows for simultaneous detection
Purification and detection tags:
fusion proteins
• Cloned herds of
transgenic or gene-
targeted farm animals
that produce valuable
human proteins.
• Produce human
growth hormone,
blood clotting factors
in milk – “pharm
animals”
Transgenic plants
• Crop plants engineered for
increased herbicide
resistance
• Altered plant architecture
(height) for improved
productivity
• Improved tolerance to
environmental stresses,
drought
• Improved nutritional
properties
– Rice contain genes encoding β-
carotene
– Precursor for vitamin A
– Vitamin A deficiency affects
millions, causing death &
blindness
Gene Therapy
• Three types:
1. Ex vivo: cells removed from body, incubated with vector and return –
bone marrow cells
2. In situ: vector applied directly to affected tissues – used in treatment
of cystic fibrosis by inhaling an aerosol containing a vector encoding
the normal protein
3. In vivo: vector injected directly into bloodstream
Summary
• Recombinant protein production: bacteria
• Eukaryotic protein production in bacteria
• Problems / solutions
• Site-Directed Mutagenesis – PCR (proof-reading)
• Reporter Genes: examples
• Tags
• Gene Therapy – definitions, different types